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Background: Rabies is preventable through prompt administration of post-exposure prophylaxis (PEP) to
exposed persons, but PEP access is limited in many rabies-endemic countries. We investigated how
access to PEP can be improved to better prevent human rabies.
Methods: Using data from different settings in Tanzania, including contact tracing (2,367 probable rabies
exposures identified) and large-scale mobile phone-based surveillance (24,999 patient records), we esti-
mated the incidence of rabies exposures and bite-injuries, and examined health seeking and health out-
comes in relation to PEP access. We used surveys and qualitative interviews with stakeholders within the
health system to further characterise PEP supply and triangulate these findings.
Results: Incidence of bite-injury patients was related to dog population sizes, with higher incidence in
districts with lower human:dog ratios and urban centres. A substantial percentage (25%) of probable
rabies exposures did not seek care due to costs and limited appreciation of risk. Upon seeking care a fur-
ther 15% of probable rabies exposed persons did not obtain PEP due to shortages, cost barriers or misad-
vice. Of those that initiated PEP, 46% did not complete the course. If no PEP was administered, the risk of
developing rabies following a probable rabies exposure was high (0.165), with bites to the head carrying
most risk. Decentralized and free PEP increased the probability that patients received PEP and reduced
delays in initiating PEP. No major difficulties were encountered by health workers whilst switching to
dose-sparing ID administration of PEP. Health infrastructure also includes sufficient cold chain capacity
to support improved PEP provision. However, high costs to governments and patients currently limits the
supply chain and PEP access. The cost barrier was exacerbated by decentralization of budgets, with
priority given to purchase of cheaper medicines for other conditions. Reactive procurement resulted in
limited and unresponsive PEP supply, increasing costs and risks to bite victims.
Conclusion: PEP access could be improved and rabies deaths reduced through ring-fenced procurement,
switching to dose-sparing ID regimens and free provision of PEP.
 2018 Published by Elsevier Ltd. This is an open access article under the CC BY IGO license. (http://crea-
tivecommons.org/licenses/by/3.0/igo/).1. Introduction
The burden of human rabies is high in many low- and middle-
income countries (LMICs) where the disease is maintained and
spread primarily by domestic dogs [1]. Following onset of
symptoms, rabies is invariably fatal [2], however disease can beprevented in exposed persons through timely Post-Exposure
Prophylaxis (PEP). The World Health Organization (WHO) recom-
mended protocol for PEP includes immediate wound washing,
administration of rabies vaccine and in severe exposures, infiltra-
tion of purified rabies immunoglobulin (RIG) into the wound(s)
[1]. However PEP is expensive and costs can be a major obstacle
to both bite victims and to local and national governments in
LMICs [3,4]. In some countries PEP is therefore bought only in
relatively small amounts and distributed to a limited set of
facilities. High out-of-pocket costs for bite victims paying for PEP
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heightened rabies risks and even deaths, which are disproportion-
ate in poor and marginalized communities [3]. Thus, although
rabies is entirely preventable, limited access to PEP is thought to
be a major reason why so many human rabies deaths continue to
occur. Improving access to PEP for persons bitten by rabid animals
is therefore crucial to achieving the goal of zero human deaths
from dog-mediated rabies by 2030 [5].
There are a number of ways in which access to rabies PEP could
be improved. For example, rabies vaccines can be administered to
patients using dose-sparing intradermal (ID) regimens, which can
generate substantial cost savings compared to intramuscular (IM)
administration and reduce the occurrence of PEP stock-outs [6,7].
Intradermal regimens have been adopted in several countries in
Asia [8], but in most rabies endemic countries PEP is delivered
via the IM route and there is little documentation on the feasibility
and potential cost savings associated with ID administration in set-
tings in Sub-Saharan Africa. Moreover, because PEP is needed in
emergency situations, the supply chain must be responsive to this
need. However rabies incidence is lower than other priority dis-
eases in LMICs such as malaria, HIV and TB. Many persons exposed
to rabies do not seek care and their clinical outcomes are unknown.
A lack of diagnostic infrastructure means that when human rabies
victims present to facilities showing neurological syndromes they
are also often misdiagnosed [9]. The result is that health workers
must administer a complicated vaccination regimen for a disease
that they may not perceive to be common. Misdiagnosis, misadvise
and underreporting confound uncertainties around the rabies bur-
den and the potential impact of PEP. Frequent stockouts and long
distances to major health facilities where PEP is available con-
tribute to limited access [3]. Concerns remain about the opera-
tional feasibility of improving access to PEP including questions
of supply chain management, cold chain and training needs, and
on the effect of increased access to rabies PEP on demand and
impact.
In recognition of these knowledge gaps, Gavi, the Vaccine Alli-
ance, set up a learning agenda for rabies in 2013, to generate evi-
dence on the programmatic impact and operational use of
human rabies vaccines in endemic settings. We used data from
studies across different settings in Tanzania to address these
knowledge gaps, including interventions that aimed to improve
access to PEP by reducing out-of-pocket costs to patients, decen-
tralizing provision at peripheral health centres, and introducing
ID vaccination. We synthesize lessons learned from these studies
in Tanzania relating to the rabies burden, the PEP supply chain,
health seeking and compliance by persons exposed to rabies and
the efficacy of PEP.2. Methods
We conducted studies across different settings in Tanzania
including areas where interventions were undertaken to control
rabies and prevent human deaths. We examined the incidence of
rabies exposures and bites for which patients sought healthcare,
and health seeking behaviours and health outcomes in relation to
PEP access using two sources of data: contact tracing and mobile
phone-based surveillance data. Specifically we conducted contact
tracing in Serengeti and Ngorongoro districts in northern Tanzania
(2002–2017) and in 14 selected districts in southern Tanzania (4
on Pemba island, and 10 in mainland Tanzania, grouping urban
municipalities with corresponding rural districts; 2011–2017);
and implemented a rabies specific mobile phone-based surveil-
lance system across 28 districts in 7 regions of southern Tanzania
(2011–2016) [10]. Access to PEP varied across these settings.
Specifically, patients pay for PEP in most of Tanzania where it istypically only available from the district or regional hospital. This
was the case in Serengeti and Ngorongoro districts in Northern
Tanzania, but in the 28 districts in southern Tanzania PEP was pro-
vided for free through a WHO-coordinated rabies elimination
demonstration project that began in 2010 and ended in 2015
[10,11]. During this time PEP was supplied free-of-charge to hospi-
tals and selected outlying facilities in each district and training was
provided to over 300 health workers in use of the updated Thai Red
Cross ID regimen [12] as a replacement to an IM regimen (d0, d7,
d28) used elsewhere in Tanzania. We also conducted qualitative
interviews with stakeholders at different levels within the health
system to characterise the logistics associated with PEP provision
and to triangulate our findings.
2.1. Data collection
Information on rabies exposures and bites for which patients
sought healthcare, and health seeking behaviours and health out-
comes in relation to PEP access was collected through contact trac-
ing and mobile phone-based surveillance as described below.
In 2010 mobile phone-based surveillance was implemented
across 28 districts in southern Tanzania to monitor the interven-
tion undertaken to improve PEP access [10]. Mobile phones config-
ured with a surveillance application were provided to participating
facilities and health workers trained to report details of bite
patients and PEP use on standardized forms on these phones.
Mobile surveillance data was then collected routinely from January
2011 until November 2016 for these 28 districts, resulting in
24,999 records of patient presentations or 23,187 records after
removal of records of patients who travelled from outside of the
study districts.
Contact tracing began in 2002 in Serengeti and Ngorongoro dis-
tricts in northern Tanzania and in the 11 districts in southern Tan-
zania in 2011 where mobile phone-based surveillance was also
conducted. Hospital records of bite patients were used to initiate
contact tracing following previously described methods [13].
Briefly, this involved exhaustive investigations to ascertain the sta-
tus of the biting animal and identify additional bite victims who
did not seek care. A biting animal was considered probable for
rabies, according to WHO case definitions [14], if at least 2 clinical
signs were evident and the animal died, was killed or disappeared
within a 10 day period of the exposure. From tracing 5,168 patients
who presented to health centres with bite injuries, we identified
2,367 who were exposed to bites by probable rabid animals
(including 484 who did not report to a health centre). Where pos-
sible samples were collected from biting animals and cases con-
firmed either through field testing using a rapid diagnostic kit
(Bionote, Korea), or by real-time PCR assay undertaken at the Ani-
mal and Plant Health Agency (APHA) in the UK [15]. The Bionote
rapid diagnostic tests have been validated in field and laboratory
settings [16,17]. We used the PCR assay because it has been shown
to be sensitive and specific even on degraded samples such as
those sent from Tanzania, whereas the gold standard OIE tests
FAT and RTCIT are sensitive to degradation [18,19]. We previously
validated our classification of animals as probable rabid according
to WHO definitions using these tests, with 83% of samples from
animals classified as probable for rabies testing positive by PCR
(n = 313) and 90% using the rapid diagnostic kits (n = 175) [15].
A survey was used to describe the supply chain for PEP in
Dodoma region in Tanzania where no interventions had been
implemented to improve access. The survey was conducted from
April to June 2016 targeting health workers responsible for
requesting essential medicines in 92 public health facilities and 5
pharmacists responsible for managing these requests at district-
and regional-level. In addition, between May and June 2017, pur-
posively sampled stakeholders from the health system in Dodoma
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PEP management. These comprised 17 participants from both pub-
lic and private facilities; 3 health workers responsible for adminis-
tering PEP to bite victims from three health facilities; 3
pharmacists from these same facilities responsible for requesting
PEP; 4 immunisation and vaccination officers (two at district-
level and two at regional-level); 5 national officials from the
Ministry of Health, Community Development, Gender, Elderly
and Children (MoHCDGEC); and 2 pharmacists from private suppli-
ers. The national officials included two from the parastatal health
supply chain arm, the Medical Stores Department (MSD), involved
in procurement and customer service; one from the Immunisation
and Vaccination Department (IVD) and two from the Department
of Preventive Services. Interviews were conducted in Swahili at
participants’ place of work and took around 45 min each, covering
the logistics of procurement, distribution, storage and use of PEP.
Recordings were subsequently transcribed and translated into
English.2.2. Data analysis
2.2.1. Incidence of bite-injury patients and probable rabies exposures
We used the mobile phone-based surveillance records from
2011 to 2016 to quantify the incidence of patients presenting to
clinics in Southern Tanzania due to animal bites as well as clinic
records used for contact tracing in Serengeti and Ngorongoro dis-
tricts from 2003 to 2006 prior to district-wide dog vaccination
campaigns, adjusting population sizes under district population
growth rate projections [20]. We used a generalized linear mixed
effects model (GLMM) to model bite patients per 100,000 at
district-level, with setting (urban/rural) and estimated human:dog
ratios [21] examined as predictors, and year and district as random
effects. We also determined the average annual incidence of prob-
able rabies exposures in Serengeti and Ngorongoro districts from
contact tracing.2.2.2. Rabies risk and effectiveness of PEP
To estimate the protective effect of PEP we used a subset of the
contact tracing data. Only individuals bitten by probable rabid ani-
mals were considered (n = 2,367), with individuals that received
RIG (n = 1) or whose deaths were caused by tetanus or injury
(n = 1 and 5, respectively) removed. We grouped exposures accord-
ing to the part of the body where the person had been bitten. Indi-
viduals who did not provide details of bite location (n = 504) were
excluded for this. For individuals with multiple bites (n = 290),
only the highest risk bite was used for this categorization, estab-
lished via the following hierarchy of risk (head > arms/hands >
legs/feet > trunk) [22]. Based on the health outcomes of bite
victims who did not receive PEP the probability of developing
rabies following a bite to a specific body part was calculated. We
subsequently re-checked the risk hierarchy and re-categorized
exposures with the new hierarchy (head > trunk > arms/hands >
legs/feet), re-calculating the probability of death according to bite
site. Using these groupings we calculated the probability that in
the absence of post-exposure vaccination a person would develop
rabies given the site of the bite. By simulating from a mixture
model, we estimated the probability of an exposed person develop-
ing rabies in the absence of PEP using these data on bite sites and
infection.
Using the contact tracing data we assessed bite patients timeli-
ness and completion of post-exposure vaccination (hereafter
referred to as PEP, as RIG was only provided to a single patient in
this study). We defined ‘timely’ PEP as initiated on the same day
as the bite, and ‘late’ PEP as initiated more than 24 h after the bite.
We considered 3 or more doses of PEP ‘complete’ and fewer than 3doses ‘incomplete’. We then calculated the effectiveness of com-
plete PEP and incomplete or late PEP in preventing rabies.2.2.3. Health seeking, PEP access and provision
We used contact tracing data to determine what proportion of
bite patients presenting to clinics were due to probable rabid ani-
mals, animals of unknown status and healthy animals, and what
proportion of probable rabies exposures sought and obtained
PEP. From the contact tracing data we present the variability in
patient delays to initiating PEP (n = 1,388). We also compare rates
of completion of PEP between districts in northern Tanzania where
patients pay for PEP (1,655 probable rabies exposures) and districts
from southern Tanzania with free PEP (703 probable rabies expo-
sures). We also assess variability in the number and location of
facilities that patients visited for PEP, including the travel distance
from their village (centroid) to the facility, from the mobile surveil-
lance records in Southern Tanzania.
Interview data on PEP provision from health system stakehold-
ers were coded using Framework analysis [23], guided by the topic
questions, with inclusion of emerging themes. The framework
approach outlined four levels of analysis: familiarisation with the
data; identification of themes (forecasting, requisition and pro-
curement, distribution, storage, monitoring, administration and
reporting); coding interviewee responses to themes; and
interpretation.2.3. Ethical clearance
This work was approved by the Institutional Review Board of
Ifakara Health Institute (IHI/IRB/No: 011-2016), the Medical
Research Coordinating Committee of the National Institute for
Medical Research of Tanzania (NIMR/HQ/R.8a/Vol.IX/946) and the
University of Glasgow MVLS college ethics committee
(200150148). A letter of approval to conduct interviews with key
informants responsible for PEP was obtained from the MoHCDGEC
on April 18, 2017.3. Results
3.1. Incidence of bite-injury patients and probable rabies exposures
The average incidence of bite injuries in patients presenting to
health facilities varied considerably across Tanzania by district
(Fig. 1), from less than 4 patients/100,000 persons per year to over
120/100,000. We found that bite-injury incidence was negatively
correlated with human:dog ratios, i.e higher incidence in districts
with more dogs per capita (regression coefficient: 25.298,
p < 0.01, Std. Error: 8.220) and also higher in urban areas compared
to rural areas once human:dog ratios were accounted for (coeffi-
cient: 47.56, p < 0.05, Std. Error: 22.634).
We detected an average of 75.6 and 19.3 probable rabies expo-
sures per 100,000 persons per year in northern Tanzania from Ser-
engeti and Ngorongoro districts, respectively, prior to the
implementation of regular dog vaccination campaigns. These dis-
tricts have low human:dog ratios (4.5 and 7, respectively) and bite
victims must pay for PEP, as is routine in Tanzania. About 36% of
patient presentations at health facilities were due to bites from
probable rabid dogs (1,878/5,162 patients that sought care) as
assessed through contact tracing, with the remainder from healthy
animals or animals with unknown status. Around 25% of probable
rabid dog bite victims identified through contact tracing in Seren-
geti and Ngorongoro did not seek care (418/1,655), and would
therefore not be captured in health facility surveillance records
(such as the mobile phone-based surveillance).
Fig. 1. Variation in the annual incidence of patients presenting to clinics across Tanzania with bite injuries. Points are ordered by the estimated human:dog ratio for each
district, and districts are coloured according to whether they are urban or rural. Data from twenty-eight districts in Southern Tanzania (2011–2016) are shown together with
data from Serengeti and Ngorongoro (2003–2006, prior to routine annual dog vaccination campaigns). Black points show the average annual incidence, coloured points show
annual data and the box and whiskers show the range and interquartile range.
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In the absence of PEP, we estimated that the risk of developing
rabies from a probable rabid animal bite was 0.165 (95%CI 0.133–
0.201), based on the proportion of victims bitten on different parts
of the body and the risk of infection given the bite site (Table 1).
Bites to the head and the neck carried the greatest risk of rabies
(probability = 0.385, 95%CI 0.234–0.554), but bites to the trunk
were also very high risk (probability = 0.215, 95%CI 0.123–0.335).
From contact tracing we found that PEP administration was effec-
tive in preventing the onset of rabies in 473 patients exposed to
probable rabid dogs who all promptly received PEP (vaccinationTable 1
Probable rabies exposures and deaths according to the site of the body where bitten and
mixture model given the locations on the body where people were bitten.
Bite location Probability of death (95% CI) Number of
deaths
Probable rabi
did not receiv
Head 0.385 (0.234–0.554) 15 39
Trunk 0.215 (0.123–0.335) 14 65
Arm/hands 0.141 (0.086–0.213) 18 128
Leg/feet 0.127 (0.087–0.176) 30 237
Overall 0.165 (0.133–0.201) 77 469within 1 day of the exposure, but no RIG) and completed the course
(at least 3 doses). For this sample size, we estimate that prompt
timely (adequate) post-exposure vaccination prevents rabies with
probability 1.00 (95%CI 0.992–1.00). Of 1005 individuals identified
during contact tracing who received late and/or incomplete post-
exposure vaccination, 14 died showing clinical signs of rabies
(Table 2), although none were laboratory confirmed. The probabil-
ity of developing rabies under inadequate PEP (more than 1 day
late and/or less than 3 doses) was calculated as 0.014 (95%CI
0.008–0.023), i.e. inadequate PEP prevents rabies with probability
0.986 (95% CI 0.977–0.992). Nine of these deaths were attributablewhether PEP was administered. Overall probability of death was estimated from a
es exposures that
e PEP
Probability of bite depending
on location on body
Number of probable
rabies exposures
0.088 (0.076–0.102) 164
0.138 (0.122–0.155) 258
0.315 (0.293–0.335) 586
0.459 (0.436–0.481) 855
– 1863
Table 2
Details of human rabies deaths where some form of PEP was received. Two bite victims received 4 doses of vaccine but in both cases there were delays in administering PEP
(4 days and 5 days, respectively). One patient developed rabies after prompt vaccination, but completed only 2 vaccine doses. IM = Intramuscular, ID = Intradermal.
PEP Failure Age (years) Sex Doses received Route of PEP Days till PEP Number of wounds Location of Bite(s)
Delayed 14 Male 4 IM 5 1 Arm
Delayed 3 Female 4 IM 4 1 Hand
Delayed 3 Male 3 IM 1 1 Head
Delayed & Incomplete 6 Female 2 IM 10 1 Hand
Delayed & Incomplete 16 Male 2 IM 6 2 Arm, Hand
Delayed & Incomplete 7 Male 2 IM 1 3 Head, Hand, Trunk
Delayed & Incomplete 8 Female 2 IM 1 2 Head, Hand
Incomplete 11 Male 2 ID 0 2 Head, Trunk
Delayed & Incomplete 5 Male 1 IM 3 1 Hand
Delayed & Incomplete 21 Male 1 IM 1 1 Head
Incomplete 85 Male 1 ID 0 1 Leg
Incomplete 8 Male 1 ID 0 2 Head, Foot
Incomplete 9 Male 1 ID 0 1 Head
Incomplete 70 Female 1 ID 0 4 Arm, Hand, Trunk, Leg
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exposure vaccination without delay but completion of only 1–2
doses (Table 2).
3.2. Health seeking, PEP access and provision
Throughout most of Tanzania, PEP is still administered follow-
ing a 3-dose IM schedule (d0, d7, d28) [4], despite national guide-
lines being updated in 2013 and 2017 to recommend the 5-dose
Essen IM regimen and the 4-dose Updated Thai Red Cross ID regi-
men [24,25]. Typically patients must also pay for PEP. However, in
districts where the WHO-coordinated rabies elimination project
took place, the updated Thai Red Cross ID schedule is now used
routinely. ID administration was introduced to designated health
workers responsible for PEP as part of the project during a one-
day workshop [11]. On-job training in the mobile phone-based
surveillance system, including further instruction in ID vaccination
was completed, taking around 3 h at each facility [10,11]. No major
difficulties were encountered in switching to ID administration,
however health workers reported occasional shortages of needles
for ID use [11]. RIG use in Tanzania is negligible; none of the inter-
viewed health workers reported ever using RIG, except for those
from Dar es Salaam who were only aware of RIG from the WHO-
coordinated project.
Bite patients are first required to consult a clinician for wound
assessment, including payment of a consultation fee, before being
referred for PEP to the Reproductive and Child Health (RCH) unit,
which provides vaccination services. RCH units open Monday
through Friday 8 am to 2 pm, with patients reporting out of hours
required to wait till the RCH opens. In Dar es Salaam, bite victims
should present a letter from the veterinary department before
receiving PEP. The purpose of these letters is to help health work-
ers ascertain the health status of the biting animal and to enable
livestock officers to follow up the biting animal in case of an out-
break. However, few bite victims complete this process and live-
stock officers rarely investigate biting animals.
In Tanzania payment procedures for PEP differ by facility; some
health workers collect payment directly, while some patients pay
at the facility cashier before vaccination. Only a small proportion
of patients pay via health insurance (<10% of Tanzanian citizens
have insurance) [26]. Exemption to vulnerable groups and waivers
to poor bite victims were reported during stakeholder interviews,
but PEP was generally not considered to be part of exemption ser-
vices. The cost charged for PEP typically included a marginal profit
to enable facilities to continue stocking it, at the discretion of dis-
trict authorities. Most facilities including private pharmacies
charge around 30,000 Tanzania shillings ($13) for a 1 ml or
0.5 ml vaccine vial. Participants from the main health centre inDar es Salaam reported now charging per clinic visit at
15,000 TSh ($7) for 2  0.1 ml intradermal injections, recovering
around 60,000–75,000 TSh ($27–33) per vial. Some patients also
purchase vaccine at private pharmacies and bring these to RCH
units for administration.
In Serengeti and Ngorongoro district where patients pay for PEP,
25.3% (418/1,655) of probable rabies exposed persons did not seek
care, citing both costs and lack of awareness about rabies. On seek-
ing care a further 15.3% (189/1,237) still did not initiate PEP due to
costs, shortages or occasionally incorrect advice (usually at periph-
eral centres that should refer patients). Delays to administration of
PEP were also common. Most probable rabies exposed persons
who initiated PEP did so on the same day as exposure (Fig. 2A).
However, in northern Tanzania, where patients pay for PEP, the
median delay for those that initiated PEP was 2 days, whereas in
Southern Tanzania, where PEP was provided for free, the median
delay to initiating PEP was zero days (Fig. 2A). Some rabies exposed
persons reported to health facilities only after a delay of several
months, sometimes only after another person bitten by the same
animal showed signs of rabies. Delays were often conflated with
non-completion, as a consequence of barriers to access, including
costs and limited availability from only a few facilities. Decentral-
ized and free supply of PEP, as implemented in the 28 districts in
southern Tanzania from 2010 onwards [11], was associated with
a higher probability of patients initiating PEP (0.899 versus 0.873
in Serengeti and Ngorongoro; Fig. 2B). However, around 6%
(1,458/23,150) of these patients in southern Tanzania also faced
shortages, although they might have obtained PEP subsequently
at another facility. A relatively low proportion of patients com-
pleted at least 3 doses of PEP (47.3% of patients from mobile
surveillance records in southern Tanzania versus 54.2% of rabies
exposed bite victims, identified through contact tracing, who initi-
ated PEP, Fig. 2B).
In the districts in southern Tanzania with improved PEP access,
89.8% (18,418/20,514 excluding records where health facility name
was not recorded) of patients obtained PEP from a single health
facility, with the remainder seeking and obtaining PEP at multiple
(up to 4) health facilities. About 37.7% (7,735/20,514) travelled
outside of their home district to receive PEP, and 4.6%
(948/20,514) travelled to another region (Fig. 3). Interviewees
reported that PEP access had declined throughout Tanzania after
the Ministry of Health discontinued centralized PEP procurement
in 2012 and issued a directive that instead local government
authorities allocate funds for PEP. Areas covered by the WHO-
coordinated rabies elimination demonstration project only experi-
enced this decline after the project ended in 2015. Bite victims
were reported to often travel from other regions where PEP is
not available in either public or private clinics. From the mobile
Fig. 2. Initiation and completion of post-exposure vaccination according to access: (A) delay between date bitten and first post-exposure vaccination for individuals bitten by
probable rabid animals and (B) proportion of patients that received 1–5 doses of PEP. Blue indicates locations where patients were required to pay for PEP (Serengeti and
Ngorongoro) and yellow indicates locations where PEP was provided for free (28 districts in Southern Tanzania). Panel A shows contact tracing data on delays between
exposure and initiation of PEP for rabies exposed persons (781 exposures from Serengeti and Ngorongoro districts, and 607 exposures from 11 districts in southern Tanzania).
Out of 794 patients identified through contact tracing who had delayed PEP (more than 1 day late), nine deaths occurred (Table 2). Panel B shows mobile phone-based
surveillance records from Southern Tanzania (yellow, n = 21,692) of PEP completion and contact tracing data on rabies exposed patients from Serengeti and Ngorongoro
districts (n = 1,200). Not all bite victims received the first PEP dose because of shortages at the facility or costs required to purchase PEP. Rabies exposed persons who did not
seek care (identified through contact tracing) are not shown. In Serengeti district patients were typically vaccinated following a 3 dose IM regimen (d0, d7, d28) and in
Ngorongoro district following the 5-dose Essen IM regimen (d0, d3, d7, d14, d28). In southern Tanzania, most patients were vaccinated following the updated Thai Red Cross
ID regimen (d0, d3, d7, d28).
A50 J. Changalucha et al. / Vaccine 37 (2019) A45–A53surveillance records 7.25% (1,812/24,999) of patients originated
from outside of the study districts where PEP was provided for free
(these patients were not included in all other reported statistics).Patients from districts in southern Tanzania travelled an average
distance (as the crow flies) of 30 km (95%CI 1–116 km) from their
home to a health facility (range: 0–673 km). If all health facilities
Fig. 3. Schematic of the number of visits to health facilities made by patients to obtain PEP within their district, in other district in their region, and in other regions. All clinic
visits were from patients located within the study districts. The schematic also shows the proportion of visits made to multiple facilities and their locations.
J. Changalucha et al. / Vaccine 37 (2019) A45–A53 A51had provided PEP, this travel distance could have been reduced to
12 km (95% CI 1–37 km).
Both rabies vaccines and RIG are listed as essential medicines
that are supplied by MSD to public health facilities through the
Tanzanian Integrated Logistics System (ILS) [27], and to private
facilities on request. However, although classified for administra-
tion at hospitals and health centers [24], PEP is not listed among
the 251 predetermined priority medicines in the ILS requisition
forms, bought from the allocated MOH budget for quarterly supply.
As a consequence, PEP is procured through district funds obtained
from other sources, for example basket funds (pooled donor and
government funds to support the implementation of the Health
Sector Strategic Plan IV) and funds recovered from health insur-
ance or out-of-pocket payments. One pharmacist stated ‘‘the money
is not enough, that is why we normally say let’s just get this money
from this source and buy” (respondent 3). Because of this atypical
and unpredictable financing, PEP is usually procured outside the
MSD distribution calendar, therefore facilities normally arrange
collection themselves. Private suppliers are used to source medical
supplies when MSD is out of stock. During stockouts, MSD issues
an out-of-stock form to allow facilities to purchase PEP from pri-
vate suppliers and all requests are directed to specific pre-
qualified private suppliers (denoted prime vendors). Some private
retailers reported preferring to source cheaper PEP because the
price from some suppliers was unaffordable for bite victims, but
this also led to stocking delays. Interviewees stated that PEP
stock-outs were common, usually lasting for around two months,
although sometimes for shorter periods (days to weeks). Delays
in recovering funds were reported to contribute to stockouts, as
some private suppliers refused to resupply health facilities with
standing debts.
There is no PEP forecasting at district or regional level, so pur-
chase is only made once stocks are depleted. At MSD, customers
are required to show the source of their revenue in relation to their
demand, therefore the amount of PEP procured depends on funds
in hand even if costs are expected to be recovered through, for
example, insurance. Both MSD and health facilities only procure
PEP if they can guarantee cost recovery. The resulting supply chainis therefore not responsive to fluctuations in PEP demand, such as
during outbreaks when presenting patients exceed available stock.
As reported by one pharmacist ‘‘. . ...the forecast is difficult because
the patients are unpredictable . . .. after a long period of vaccine short-
age, the other health facilities stopped providing services, and you will
see all burden coming to us” (respondent 1).
The cold chain system was considered by interviewees to be
satisfactory, with every district and region equipped with large
refrigerators, and most health facilities (>90%) with small refriger-
ators. However, these refrigerators are prioritized to store vaccines
by the Immunisation and Vaccination Development department
(formerly EPI). Health workers were concerned that criteria used
for evaluating health facility performance disincentivize storage
of PEP. In practice PEP are usually stored with routine vaccines
but participants suggested guidelines should be revised ‘‘. . ...One
of the things which they do in the routine vaccine to assess the perfor-
mance of a facility in storage, is on assessing if their fridge is not keep-
ing other vaccine other than the routine vaccine. . . ...credits are
deducted for those facilities found keeping other vaccine” (respondent
16).
No standard tools are used for tracking PEP use and bite victims
are not issued with vaccination cards as for routine vaccination.
Instead health workers use registers to record bite victims. These
differ by facility but usually include the patient address, bite site
and PEP dose. The infectious disease weekly ending (IDWE) report
is used by MOH for reporting bite patients to national level
(whether or not they obtained PEP) on a weekly basis.4. Discussion
We show that although post-exposure vaccination is highly
effective in preventing rabies, even in the absence of RIG, costs to
patients and governments are a major obstacle limiting access in
Tanzania. These high costs directly affect how PEP is distributed,
with PEP only procured reactively and in limited quantities. Out-
of-pocket payments increase if patients need to travel to multiple
clinics due to stockouts. The risk of developing rabies is very high
A52 J. Changalucha et al. / Vaccine 37 (2019) A45–A53for rabies exposed patients who do not obtain PEP and also
increase with delays to PEP initiation and noncompletion.
Nonetheless, an effective cold chain and demonstrated success in
switching to ID administration highlight opportunities for improv-
ing PEP access, especially if the primary cost barrier could be over-
come through free provision, like other immunisation services.
Access to PEP is limited in many countries with endemic rabies
and PEP is often only available from health facilities in the capital
city [28]. Patients also generally need to pay for PEP and these costs
are reported as a major obstacle for many bite victims. In Tanzania
health policy recognizes immunisation as a free service [29], but
bite victims are required to pay for PEP and a concerning propor-
tion do not initiate PEP or are delayed because of costs (both direct
and indirect) [3,30]. Although health insurance reduces out-of-
pocket payments for healthcare [31], less than 10% of Tanzanians
are insured [26]. Exemption and waivers to cost-sharing occasion-
ally enable poor bite victims to obtain PEP for free, but procedures
are cumbersome and inefficient [32], which may also delay initiat-
ing PEP. Even though PEP costs are borne largely by bite victims,
high costs to local and national governments further limits avail-
ability and results in frequent stockouts. Other essential medicines
are prioritized, leaving insufficient funds for PEP procurement.
Although ILS was designed as an efficient platform for essential
medicine delivery [27], various limitations render it ineffective
for PEP [33] and district resource allocation tools (CCHP, IFMS
and EPICOR systems) disadvantage PEP compared to other essen-
tial medicines [34,35].
In Tanzania, the incidence of bite injuries requiring PEP is highly
variable. The size of dog populations influences incidence; in dis-
tricts with many dogs (low human:dog ratios) bite-injuries are cor-
respondingly higher. A large proportion of these bite patients are
probable rabies exposures who urgently require PEP. The high
costs of PEP likely explain the high proportion of bite patients
due to rabid dogs in Tanzania, as persons with non-severe bites
from evidently healthy dogs may be less likely to seek treatment,
whereas those bitten severely and by high risk dogs generally seek
care. In settings in Southeast Asia where PEP is subsidized, health
seeking can be much higher [28,34–37]. In these settings, although
a much smaller proportion of bites are attributed to probable rabid
animals compared to our study sites in Tanzania, PEP is often
administered also in the event of healthy animal bites. If PEP were
to be provided for free in Tanzania, training in integrated bite case
management could limit unnecessary PEP administration to per-
sons bitten by healthy or vaccinated animals [38,39]. Knowledge
of the size of dog populations could also inform PEP allocation,
but the supply chain needs to be responsive, which requires the
use of tools for tracking PEP use.
Experiences from southern Tanzania highlighted opportunities
for improving access to PEP and reducing rabies deaths. Provision
of PEP free-of-charge improved health seeking [10,11], while
switching to dose-sparing ID regimens required only minimal
training [10,11]. During a recent shortage of PEP in Dodoma region,
researchers were able to facilitate access by obtaining vaccine from
another region and training clinicians in ID administration to
enable more patients to be treated with the limited supply. More
generally, training for health workers could facilitate adoption of
the latest WHO recommendations for accelerated PEP that aims
to reduce direct and indirect costs to bite victims [1]. Further train-
ing would also be necessary if tools were introduced to track PEP
use. The wide coverage of an effective cold chain system [40],
strengthened through EPI, also provides infrastructure for PEP stor-
age, although guidelines need updating to incentivise safe storage
of PEP. Similarly, RCH units need to better accommodate PEP
scheduling to ensure that patients can receive these life-saving
vaccines without delay. Although the current supply chain for
PEP in Tanzania has major limitations, the efficiency of verticalprograms in controlling TB and HIV/AIDS in many LMICs [41],
including EPI for childhood immunizations, demonstrate that
alternative supply systems can be effectively implemented, when
medicines are considered a public good and universal health cover-
age is promoted.
We have brought together diverse data on the incidence of
rabies exposures and bite patients, and on healthcare utilization
and provision across different parts of Tanzania. However, not all
of these data are directly comparable, given differences in dog
population sizes, dog vaccination effort and provision of health ser-
vices. The probability that a bite patient receives PEP is likely to be
overestimated based on stockouts reported from mobile surveil-
lance records, as patients may subsequently seek and obtain PEP
elsewhere. Hence the benefits of free PEP provision may not be
fully captured from health records that do not longitudinally track
individual health seeking outcomes. In contrast estimates from
contact tracing should capture these aspects of health seeking,
but may be more subject to inaccuracies in bite victim recall. Con-
tact tracing itself may also increase PEP compliance as bite victims
are advised regarding essential rabies prevention strategies during
interviews. We also report the effectiveness of PEP in preventing
rabies based on exposures from probable but not confirmed rabid
dogs. However, we have found high correspondence between prob-
able rabies cases identified on the basis of their clinical history and
on subsequent laboratory confirmation (83–90%) [15].
5. Conclusion
A large number of preventable deaths from rabies occur in
Tanzania due to poor access to PEP. We conclude that free provi-
sion of PEP at point-of-care, ring-fenced PEP procurement, switch-
ing to recommended dose-sparing ID regimens, and ensuring
responsive and accountable supply chains for PEP are all feasible
approaches that should reduce the burden of human rabies.
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